Pixilab
Home › Companies › SEC Form D - Biotechnology › Apex Therapeutics, Inc.

Apex Therapeutics, Inc.

SEC Form D private-offering issuer in Biotechnology

Operating in sec form d - biotechnology based in INDIANAPOLIS, INDIANA, Apex Therapeutics, Inc. was founded in 2008.

Profile

Private US issuer recorded in the SEC Form D structured dataset for 2012Q4. Industry: Biotechnology. Revenue range: $1 - $1,000,000. Offering amount: 2000000.

Within the sec form d - biotechnology space, the company focuses on its core offering rather than a broad product line.

INDIANAPOLIS, INDIANA is where the company is located.

The company is listed at the Regulation D stage of development.

Recorded headcount: 11-50 employees.

It has disclosed roughly $2M in funding.

SectorSEC Form D - Biotechnology
HeadquartersINDIANAPOLIS, INDIANA
CountryUnited States
Founded2008
Employees11-50
StageRegulation D
Total funding$2,000,000

Website: apextherapeutics.com

Browse related

More SEC Form D - Biotechnology companies Companies in United States Companies founded in 2008
Sign in to view the contact information we hold for Apex Therapeutics, Inc..
Create a free account